An update on belimumab for the treatment of lupus

by Aikaterini Thanou-Stavraki, Amr H Sawalha
Published 2011-02-01

Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers

by Joan T Merrill, Eliza Chakravarty, Aikaterini Thanou, Teresa Aberle, Fredonna Carthen, Stan Kamp, Motolani E Ogunsanya
Published 2020-12-01

Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study

by Joel M. Guthridge, Rufei Lu, Ly Thi-Hai Tran, Cristina Arriens, Teresa Aberle, Stan Kamp, Melissa E. Munroe, Nicolas Dominguez, Timothy Gross, Wade DeJager, Susan R. Macwana, Rebecka L. Bourn, Stephen Apel, Aikaterini Thanou, Hua Chen, Eliza F. Chakravarty, Joan T. Merrill, Judith A. James
Published 2020-03-01

Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus...

by Rebecca A. Wood, Lauren Guthridge, Emma Thurmond, Carla J. Guthridge, Joseph M. Kheir, Rebecka L. Bourn, Catriona A. Wagner, Hua Chen, Wade DeJager, Susan R. Macwana, Stan Kamp, Rufei Lu, Cristina Arriens, Eliza F. Chakravarty, Aikaterini Thanou, Joan T. Merrill, Joel M. Guthridge, Judith A. James
Published 2021-01-01